Literature DB >> 12417483

Mycobacterium terrae isolated from indoor air of a moisture-damaged building induces sustained biphasic inflammatory response in mouse lungs.

Juha Jussila1, Hannu Komulainen, Kati Huttunen, Marjut Roponen, Eila Iivanainen, Pirjo Torkko, Veli-Matti Kosma, Jukka Pelkonen, Maija-Riitta Hirvonen.   

Abstract

Occupants in moisture-damaged buildings suffer frequently from respiratory symptoms. This may be partly due to the presence of abnormal microbial growth or the altered microbial flora in the damaged buildings. However, the specific effects of the microbes on respiratory health and the way they provoke clinical manifestations are poorly understood. In the present study, we exposed mice via intratracheal instillation to a single dose of Mycobacterium terrae isolated from the indoor air of a moisture-damaged building (1 X 10(7), 5 X 10(7), or 1 X 10(8) microbes). Inflammation and toxicity in lungs were evaluated 2 hr later. The time course of the effects was assessed with the dose of 1 X 10(8) bacterial cells for up to 28 days. M. terrae caused a sustained biphasic inflammation in mouse lungs. The characteristic features for the first phase, which lasted from 6 hr to 3 days, were elevated proinflammatory cytokine [i.e., tumor necrosis factor alpha (TNF-alpha) and interleukin-6 (IL-6)] levels in the bronchoalveolar lavage fluid (BALF). TNF-alpha was produced in the lungs more intensively than was IL-6. Neutrophils were the most abundant cells in the airways during the first phase, although their numbers in BALF remained elevated up to 21 days. The characteristics of the second phase, which lasted from 7 to 28 days, were elevated TNF-alpha levels in BALF, expression of inducible nitric oxide synthase in BAL cells, and recruitment of mononuclear cells such as lymphocytes and macrophages into the airways. Moreover, total protein, albumin, and lactate dehydrogenase concentrations were elevated in both phases in BALF. The bacteria were detected in lungs up to 28 days. In summary, these observations indicate that M. terrae is capable of provoking a sustained, biphasic inflammation in mouse lungs and can cause a moderate degree of cytotoxicity. Thus, M. terrae can be considered a species with potential to adversely affect the health of the occupants of moisture-damaged buildings.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12417483      PMCID: PMC1241068          DOI: 10.1289/ehp.021101119

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  52 in total

Review 1.  Nonneoplastic lung responses induced in experimental animals by exposure to poorly soluble nonfibrous particles.

Authors:  K Donaldson
Journal:  Inhal Toxicol       Date:  2000 Jan-Feb       Impact factor: 2.724

2.  Inflammatory responses in RAW264.7 macrophages caused by mycobacteria isolated from moldy houses.

Authors: 
Journal:  Environ Toxicol Pharmacol       Date:  2000-06-01       Impact factor: 4.860

Review 3.  Inflammatory mediators of asthma: an update.

Authors:  P J Barnes; K F Chung; C P Page
Journal:  Pharmacol Rev       Date:  1998-12       Impact factor: 25.468

Review 4.  Mycobacterial lipoarabinomannan: an extraordinary lipoheteroglycan with profound physiological effects.

Authors:  D Chatterjee; K H Khoo
Journal:  Glycobiology       Date:  1998-02       Impact factor: 4.313

5.  Spontaneous resolution of a lung mass due to infection with Mycobacterium terrae.

Authors:  T H Spence; V M Ferris
Journal:  South Med J       Date:  1996-04       Impact factor: 0.954

6.  Chronic pulmonary infection caused by Mycobacterium terrae complex: a resected case.

Authors:  F Kuze; A Mitsuoka; W Chiba; Y Shimizu; M Ito; T Teramatsu; N Maekawa; Y Suzuki
Journal:  Am Rev Respir Dis       Date:  1983-09

Review 7.  Host defense against nontuberculous mycobacterial infections.

Authors:  S M Holland
Journal:  Semin Respir Infect       Date:  1996-12

8.  Pulmonary immune responses during primary mycobacterium bovis- Calmette-Guerin bacillus infection in C57Bl/6 mice.

Authors:  S A Fulton; T D Martin; R W Redline; W Henry Boom
Journal:  Am J Respir Cell Mol Biol       Date:  2000-03       Impact factor: 6.914

9.  Pulmonary disease due to Mycobacterium terrae.

Authors:  D J Palmero; R I Teres; K Eiguchi
Journal:  Tubercle       Date:  1989-12

10.  Acridine orange staining of smears for demonstration of Mycobacterium tuberculosis.

Authors:  M L Katila; R A Mäntyjärvi
Journal:  Eur J Clin Microbiol       Date:  1982-12       Impact factor: 3.267

View more
  6 in total

1.  Bacteria in a water-damaged building: associations of actinomycetes and non-tuberculous mycobacteria with respiratory health in occupants.

Authors:  J-H Park; J M Cox-Ganser; S K White; A S Laney; S M Caulfield; W A Turner; A D Sumner; K Kreiss
Journal:  Indoor Air       Date:  2016-01-21       Impact factor: 5.770

2.  Mycobacteria and fungi in moisture-damaged building materials.

Authors:  Eila Torvinen; Teija Meklin; Pirjo Torkko; Sini Suomalainen; Marjut Reiman; Marja-Leena Katila; Lars Paulin; Aino Nevalainen
Journal:  Appl Environ Microbiol       Date:  2006-10       Impact factor: 4.792

3.  Complete genome sequence of a novel clinical isolate, the nontuberculous Mycobacterium strain JDM601.

Authors:  Zhuo-Yang Zhang; Zhan-Qiang Sun; Zi-Ling Wang; Zi-Lu Wen; Qing-Wen Sun; Zhao-Qin Zhu; Yan-Zheng Song; Jun-Wei Zhao; Hong-Hai Wang; Shu-Lin Zhang; Xiao-Kui Guo
Journal:  J Bacteriol       Date:  2011-06-17       Impact factor: 3.490

Review 4.  Health impacts of environmental mycobacteria.

Authors:  Todd P Primm; Christie A Lucero; Joseph O Falkinham
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

5.  First Canadian Reports of Cervical Adenitis Due to Mycobacterium Malmoense and a 10-year Review of Nontuberculous Mycobacterial Adenitis.

Authors:  Chris McCrossin; Tim Mailman
Journal:  Can J Infect Dis Med Microbiol       Date:  2006-03       Impact factor: 2.471

6.  Diversity and seasonal dynamics of bacterial community in indoor environment.

Authors:  Helena Rintala; Miia Pitkäranta; Mika Toivola; Lars Paulin; Aino Nevalainen
Journal:  BMC Microbiol       Date:  2008-04-08       Impact factor: 3.605

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.